COMCO Competition Commission Shuts Probe Against Novartis

COMCO Competition Commission Shuts Probe Against Novartis

Swiss authority stated there was no unlawful practice

COMCO Competition Commission has terminated an investigation against Novartis into using blocking patents, without results.

In 2022, the Commission began its probe to determine whether the pharmaceutical giant intended to unlawfully protect one of its medicines by filing various patent infringement lawsuits.

In a statement, Switzerland's Commission stated, "The investigation revealed that Novartis' actions were common practice in the field of patent law. It did not confirm the indications of an unlawful restraint of competition."